Rekombinanter TACSTD2 Antikörper (AA 31-274)
Kurzübersicht für Rekombinanter TACSTD2 Antikörper (AA 31-274) (ABIN7873762)
Target
Alle TACSTD2 Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 31-274
-
Verwendungszweck
- Recombinant TROP2 Antibody / TACSTD2
-
Aufreinigung
- Protein A/G affinity
-
Immunogen
- A portion of amino acids 31-274 was used as the immunogen for the recombinant TROP2 antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the recombinant TROP2 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the recombinant TROP2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- TACSTD2 (Tumor-Associated Calcium Signal Transducer 2 (TACSTD2))
-
Andere Bezeichnung
- TROP2
-
Hintergrund
- TACSTD2 is a cell surface glycoprotein receptor. It is a single pass type I membrane protein containing one thyroglobulin type-1 domain, an epidermal growth factor-like repeat, a phosphatidylinositol binding site and tyrosine phosphorylation sites near the C-terminus. It plays a role in transducing intracellular calcium signals. It is expressed in trophoblast cells, cornea and multi-stratified epithelia. It is also highly expressed in several types of tumors and is involved in regulating the growth of carcinoma cells.
-
UniProt
- P09758
Target
-